About Fuan Pharmaceutical Company

The company was founded on February 25, 2004, and is the first enterprise successfully listed on the Shenzhen GEM in Changshou Economic and Technological Development Zone. The company is mainly engaged in R&D, production and sales of chemicals. The company's main products are gentamicin, cefazoxime sodium, cefmetazol sodium, laoxicefin, ceftazidime, torrimifene citrate tablets (formulations), ondansetron hydrochloride (APIs, preparations), granasetron hydrochloride (APIs, preparations), doxofylline (APIs, preparations), and nimegoline capsules. Sulinic acid tablets glutathione. Corporate honors: 2008 - National Key New Products; 2009 - Master's Student Practice Base; 2011 - National Key High-tech Enterprise; 2016 - High-tech Enterprise, “China's Top 100 Pharmaceutical Industry Enterprises” at the National Pharmaceutical Industry Information Annual Conference, “Top 100 Chinese Pharmaceutical R&D Comprehensive Strength”, and “China's Top 50 Pharmaceutical Research and Development Strength” at the 5th China Pharmaceutical Research and Development Summit.